Skip to main content

Peer Review reports

From: EGFR mutation testing and treatment decisions in patients progressing on first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors

Original Submission
25 Oct 2019 Submitted Original manuscript
3 Dec 2019 Reviewed Reviewer Report - Andrea De Giglio
3 Jan 2020 Reviewed Reviewer Report - Kazumi Sano
10 Jan 2020 Reviewed Reviewer Report - Jian-Guo ZHOU
14 Feb 2020 Author responded Author comments - Anne Chiang
5 Mar 2020 Reviewed Reviewer Report - Jian-Guo ZHOU
6 Mar 2020 Reviewed Reviewer Report - Andrea De Giglio
9 Mar 2020 Reviewed Reviewer Report - Kazumi Sano
23 Mar 2020 Author responded Author comments - Anne Chiang
Resubmission - Version 2
14 Feb 2020 Submitted Manuscript version 2
2 Apr 2020 Author responded Author comments - Anne Chiang
Resubmission - Version 3
2 Apr 2020 Submitted Manuscript version 3
Publishing
5 Apr 2020 Editorially accepted
28 Apr 2020 Article published 10.1186/s12885-020-06826-0

You can find further information about peer review here.

Back to article page